FGF-2 protects small cell lung cancer cells from apoptosis through a complex involving PKCɛ, B-Raf and S6K2-Reference-Cited by-同舟云学术

FGF-2 protects small cell lung cancer cells from apoptosis through a complex involving PKCɛ, B-Raf and S6K2

Published:2006-06-29 Issue:13 Volume:25 Page:3078-3088
ISSN:0261-4189
Container-title:The EMBO Journal
language:
Short-container-title:EMBO J

Author:

Pardo Olivier E,Wellbrock Claudia,Khanzada Umme K,Aubert Muriel,Arozarena Imanol,Davidson Sally,Bowen Frances,Parker Peter J,Filonenko V V,Gout Ivan T,Sebire Neil,Marais Richard,Downward Julian,Seckl Michael J

Publisher

Wiley

Subject

General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,Molecular Biology,General Neuroscience

Reference38 articles.

1. Mutation of B-Raf in Human Choroidal Melanoma Cells Mediates Cell Proliferation and Transformation through the MEK/ERK Pathway

2. Sequential Activation of Protein Kinase C (PKC)-α and PKC-ε Contributes to Sustained Raf/ERK1/2 Activation in Endothelial Cells under Mechanical Strain

3. Ectopic B-Raf Expression Enhances Extracellular Signal-regulated Kinase (ERK) Signaling in T Cells and Prevents Antigen-presenting Cell-induced Anergy

Cited by 160 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ribosomal protein S6 kinase 2 (RPS6KB2) is a potential immunotherapeutic target for cancer that upregulates proinflammatory cytokines;Molecular Biology Reports;2024-01-28

2. To Investigate Growth Factor Receptor Targets and Generate Cancer Targeting Inhibitors;Current Topics in Medicinal Chemistry;2023-12

3. Angiogenesis in Lung Cancer: Understanding the Roles of Growth Factors;Cancers;2023-09-20

4. Ribosomal Protein S6 Kinase 2 (RPS6KB2) is a Potential immunotherapeutic target for cancer with up-regulating pro-inflammatory cytokines;2023-08-25

5. Futibatinib, an Irreversible FGFR1-4 Inhibitor for the Treatment ofFGFR-Aberrant Tumors;The Oncologist;2023-06-30